Kirkham HS, Staskon F, Hira N, McLane D, Kilgore KM, Parente A, Kim S, Sawicki GS
Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis. Pediatr Pulmonol. 2018 06; 53(6):720-727.
Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Cystic fibrosis patient registries: A valuable source for clinical research. J Cyst Fibros. 2018 07; 17(4):433-440.
Cystic fibrosis patient registries: A valuable source for clinical research.
American journal of respiratory and critical care medicine
The impact of MRSA on lung function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2009 Apr 15; 179(8):734-5; author reply 735.
The impact of MRSA on lung function in patients with cystic fibrosis.
Sawicki GS, Rasouliyan L, McMullen AH, Wagener JS, McColley SA, Pasta DJ, Quittner AL
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis. Pediatr Pulmonol. 2011 Jan; 46(1):36-44.
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis.
Associations between illness perceptions and health-related quality of life in adults with cystic fibrosis. J Psychosom Res. 2011 Feb; 70(2):161-7.
Associations between illness perceptions and health-related quality of life in adults with cystic fibrosis.
Oreskovic NM, Sawicki GS, Kinane TB, Winickoff JP, Perrin JM
Travel patterns to school among children with asthma. Clin Pediatr (Phila). 2009 Jul; 48(6):632-40.
Travel patterns to school among children with asthma.
Kazmerski TM, Hill K, Prushinskaya O, Nelson E, Greenberg J, Pitts SA, Borrero S, Miller E, Sawicki GS
Perspectives of adolescent girls with cystic fibrosis and parents on disease-specific sexual and reproductive health education. Pediatr Pulmonol. 2018 08; 53(8):1027-1034.
Perspectives of adolescent girls with cystic fibrosis and parents on disease-specific sexual and reproductive health education.
Kharasch VS, Dumas HM, Haley SM, Sawicki GS, Ludlow LH, Wright EA, Jones DT, O'Brien JE
Journal of pediatric rehabilitation medicine
Bronchoscopy findings in children and young adults with tracheostomy due to congenital anomalies and neurological impairment. J Pediatr Rehabil Med. 2008; 1(2):137-43.
Bronchoscopy findings in children and young adults with tracheostomy due to congenital anomalies and neurological impairment.
Fernandes SM, Khairy P, Fishman L, Melvin P, O'Sullivan-Oliveira J, Sawicki GS, Ziniel S, Breitinger P, Williams R, Takahashi M, Landzberg MJ
Journal of the American College of Cardiology
Referral patterns and perceived barriers to adult congenital heart disease care: results of a survey of U.S. pediatric cardiologists. J Am Coll Cardiol. 2012 Dec 11; 60(23):2411-8.
Referral patterns and perceived barriers to adult congenital heart disease care: results of a survey of U.S. pediatric cardiologists.
Bessonova L, Volkova N, Higgins M, Bengtsson L, Tian S, Simard C, Konstan MW, Sawicki GS, Sewall A, Nyangoma S, Elbert A, Marshall BC, Bilton D
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor. Thorax. 2018 08; 73(8):731-740.
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor.
Rho J, Ahn C, Gao A, Sawicki GS, Keller A, Jain R
Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort Study. Am J Respir Crit Care Med. 2018 10 15; 198(8):1055-1063.
Disparities in Mortality of Hispanic Patients with Cystic Fibrosis in the United States. A National and Regional Cohort Study.
Feng LB, Grosse SD, Green RF, Fink AK, Sawicki GS
Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations. Health Aff (Millwood). 2018 05; 37(5):773-779.
Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.
Sawicki GS, Vilk Y, Schatz M, Kleinman K, Abrams A, Madden J
The Journal of asthma : official journal of the Association for the Care of Asthma
Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs. J Asthma. 2010 Jun; 47(5):574-80.
Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS, Whitworth R, Gunn L, Butterfield R, Lukens-Bull K, Wood D
Receipt of health care transition counseling in the national survey of adult transition and health. Pediatrics. 2011 Sep; 128(3):e521-9.
Receipt of health care transition counseling in the national survey of adult transition and health.
Sawicki GS, Smith L, Bokhour B, Gay C, Hohman KH, Galbraith AA, Lieu TA
Periodic use of inhaled steroids in children with mild persistent asthma: what are pediatricians recommending? Clin Pediatr (Phila). 2008 Jun; 47(5):446-51.
Periodic use of inhaled steroids in children with mild persistent asthma: what are pediatricians recommending?
Overcoming psychosocial challenges in cystic fibrosis: Promoting resilience. Pediatr Pulmonol. 2018 11; 53(S3):S86-S92.
Overcoming psychosocial challenges in cystic fibrosis: Promoting resilience.
Sawicki GS, Lukens-Bull K, Yin X, Demars N, Huang IC, Livingood W, Reiss J, Wood D
Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ--Transition Readiness Assessment Questionnaire. J Pediatr Psychol. 2011 Mar; 36(2):160-71.
Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ--Transition Readiness Assessment Questionnaire.
Hassan M, Bonafede MM, Limone BL, Hodgkins P, Sawicki GS
ClinicoEconomics and outcomes research : CEOR
The burden of cystic fibrosis in the Medicaid population. Clinicoecon Outcomes Res. 2018; 10:423-431.
The burden of cystic fibrosis in the Medicaid population.
Galbraith AA, Smith LA, Bokhour B, Miroshnik IL, Sawicki GS, Glauber JH, Hohman KH, Gay C, Lieu TA
Archives of pediatrics & adolescent medicine
Asthma care quality for children with minority-serving providers. Arch Pediatr Adolesc Med. 2010 Jan; 164(1):38-45.
Asthma care quality for children with minority-serving providers.
Sawicki GS, Strunk RC, Schuemann B, Annett R, Weiss S, Fuhlbrigge AL
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study. Ann Allergy Asthma Immunol. 2010 Jan; 104(1):30-5.
Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study.
Employment experiences among adolescents and young adults with cystic fibrosis. Disabil Rehabil. 2011; 33(11):922-6.
Employment experiences among adolescents and young adults with cystic fibrosis.
Kazmerski TM, Prushinskaya OV, Hill K, Nelson E, Leonard J, Mogren K, Pitts SAB, Roboff J, Uluer A, Emans SJ, Miller E, Sawicki GS
Sexual and Reproductive Health of Young Women With Cystic Fibrosis: A Concept Mapping Study. Acad Pediatr. 2019 04; 19(3):307-314.
Sexual and Reproductive Health of Young Women With Cystic Fibrosis: A Concept Mapping Study.
Quittner AL, Sawicki GS, McMullen A, Rasouliyan L, Pasta DJ, Yegin A, Konstan MW
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample. Qual Life Res. 2012 Sep; 21(7):1267-78.
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample.
Dellon EP, Sawicki GS, Shores MD, Wolfe J, Hanson LC
Physician practices for communicating with patients with cystic fibrosis about the use of noninvasive and invasive mechanical ventilation. Chest. 2012 Apr; 141(4):1010-1017.
Physician practices for communicating with patients with cystic fibrosis about the use of noninvasive and invasive mechanical ventilation.
Sawicki GS, Fink AK, Schechter MS, Loeffler DR, Mayer-Hamblett N
Rate and predictors of prescription of lumacaftor - Ivacaftor in the 18?months following approval in the United States. J Cyst Fibros. 2018 11; 17(6):742-746.
Rate and predictors of prescription of lumacaftor - Ivacaftor in the 18?months following approval in the United States.
Sawicki GS, Ren CL, Konstan MW, Millar SJ, Pasta DJ, Quittner AL
Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. J Cyst Fibros. 2013 Sep; 12(5):461-7.
Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes.
Kazmerski TM, Miller E, Sawicki GS, Thomas P, Prushinskaya O, Nelson E, Hill K, Miller A, Jean Emans S
Developing Sexual and Reproductive Health Educational Resources for Young Women with Cystic Fibrosis: A Structured Approach to Stakeholder Engagement. Patient. 2019 04; 12(2):267-276.
Developing Sexual and Reproductive Health Educational Resources for Young Women with Cystic Fibrosis: A Structured Approach to Stakeholder Engagement.
Grosse SD, Do TQN, Vu M, Feng LB, Berry JG, Sawicki GS
Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016. Pediatr Pulmonol. 2018 12; 53(12):1611-1618.
Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016.
Tuchman LK, Schwartz LA, Sawicki GS, Britto MT
Cystic fibrosis and transition to adult medical care. Pediatrics. 2010 Mar; 125(3):566-73.
Cystic fibrosis and transition to adult medical care.
McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study. Lancet Respir Med. 2019 04; 7(4):325-335.
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study.
Cystic Fibrosis And Ivacaftor Use: The Authors Reply. Health Aff (Millwood). 2019 02; 38(2):328.
Cystic Fibrosis And Ivacaftor Use: The Authors Reply.
Kazmerski TM, Nelson EB, Newman LR, Haviland MJ, Luff D, Leichtner AM, Hayes MM, Miller E, Emans SJ, Sawicki GS
Interprofessional provider educational needs and preferences regarding the provision of sexual and reproductive health care in cystic fibrosis. J Cyst Fibros. 2019 09; 18(5):671-676.
Interprofessional provider educational needs and preferences regarding the provision of sexual and reproductive health care in cystic fibrosis.
Lanzkron S, Sawicki GS, Hassell KL, Konstan MW, Liem RI, McColley SA
Journal of clinical and translational science
Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities. J Clin Transl Sci. 2018 Oct; 2(5):334-342.
Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities.
Flewelling KD, Sellers DE, Sawicki GS, Robinson WM, Dill EJ
Social support is associated with fewer reported symptoms and decreased treatment burden in adults with cystic fibrosis. J Cyst Fibros. 2019 07; 18(4):572-576.
Social support is associated with fewer reported symptoms and decreased treatment burden in adults with cystic fibrosis.
Cystic Fibrosis Transmembrane Conductance Regulator
Cogen JD, Hall M, Loeffler DR, Gove N, Onchiri F, Sawicki GS, Fink AK
Linkage of the CF foundation patient registry with the pediatric health information system database. Pediatr Pulmonol. 2019 06; 54(6):721-728.
Linkage of the CF foundation patient registry with the pediatric health information system database.
Rosenfeld M, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Chilvers M, Higgins M, Tian S, Cooke J, Davies JC
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5?years (KLIMB). J Cyst Fibros. 2019 11; 18(6):838-843.
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5?years (KLIMB).
Lowery AS, Gallant JN, Woodworth BA, Brown RF, Sawicki GS, Shannon CN, Virgin FW
International journal of pediatric otorhinolaryngology
Chronic rhino-sinusitis treatment in children with cystic fibrosis: A cross-sectional survey of pediatric pulmonologists and otolaryngologists. Int J Pediatr Otorhinolaryngol. 2019 Sep; 124:139-142.
Chronic rhino-sinusitis treatment in children with cystic fibrosis: A cross-sectional survey of pediatric pulmonologists and otolaryngologists.
Volkova N, Moy K, Evans J, Campbell D, Tian S, Simard C, Higgins M, Konstan MW, Sawicki GS, Elbert A, Charman SC, Marshall BC, Bilton D
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries. J Cyst Fibros. 2020 01; 19(1):68-79.
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries.
Associate Professor of Psychiatry, Part-time
Walker S, Flume P, McNamara J, Solomon M, Chilvers M, Chmiel J, Harris RS, Haseltine E, Stiles D, Li C, Ahluwalia N, Zhou H, Owen CA, Sawicki G
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11?years with cystic fibrosis. J Cyst Fibros. 2019 09; 18(5):708-713.
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11?years with cystic fibrosis.
Sanders DB, Ostrenga JS, Rosenfeld M, Fink AK, Schechter MS, Sawicki GS, Flume PA, Morgan WJ
Predictors of pulmonary exacerbation treatment in cystic fibrosis. J Cyst Fibros. 2020 05; 19(3):407-414.
Predictors of pulmonary exacerbation treatment in cystic fibrosis.
Ganapathi L, Caldas A, Miranda J, Köhler JR, Visner G, Sawicki G
Medical Deferred Action - Living on Borrowed Time. N Engl J Med. 2019 Oct 24; 381(17):1601-1603.
Medical Deferred Action - Living on Borrowed Time.
Male gender and unemployment are associated with lower levels of perceived social support in adults with cystic fibrosis. J Psychosom Res. 2019 12; 127:109858.
Male gender and unemployment are associated with lower levels of perceived social support in adults with cystic fibrosis.
Suthoff E, Mainz JG, Cox DW, Thorat T, Grossoehme DH, Fridman M, Sawicki GS, Rosenfeld M
Caregiver Burden Due to Pulmonary Exacerbations in Patients with Cystic Fibrosis. J Pediatr. 2019 12; 215:164-171.e2.
Caregiver Burden Due to Pulmonary Exacerbations in Patients with Cystic Fibrosis.
Arvanitis M, Hart LC, DeWalt DA, Díaz-González de Ferris ME, Sawicki GS, Long MD, Martin CF, Kappelman MD
Transition Readiness Not Associated With Measures of Health in Youth With IBD. Inflamm Bowel Dis. 2021 01 01; 27(1):49-57.
Transition Readiness Not Associated With Measures of Health in Youth With IBD.
Survey of patients with cystic fibrosis and caregivers decisions regarding CFTR modulators. Pediatr Pulmonol. 2020 11; 55(11):2983-2989.
Survey of patients with cystic fibrosis and caregivers decisions regarding CFTR modulators.
Schechter MS, Ostrenga JS, Fink AK, Barker DH, Sawicki GS, Quittner AL
Decreased survival in cystic fibrosis patients with a positive screen for depression. J Cyst Fibros. 2021 01; 20(1):120-126.
Decreased survival in cystic fibrosis patients with a positive screen for depression.
Davies JC, Wainwright CE, Sawicki GS, Higgins MN, Campbell D, Harris C, Panorchan P, Haseltine E, Tian S, Rosenfeld M
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial. Am J Respir Crit Care Med. 2021 03 01; 203(5):585-593.
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.
Putman MS, Greenblatt LB, Bruce M, Joseph T, Lee H, Sawicki G, Uluer A, Sicilian L, Neuringer I, Gordon CM, Bouxsein ML, Finkelstein JS
The Journal of clinical endocrinology and metabolism
The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis. J Clin Endocrinol Metab. 2021 03 08; 106(3):e1248-e1261.
The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.
Scully KJ, Sawicki G, Kremen J, Putman MS
Monogenic Diabetes in a Child with Cystic Fibrosis: A Case Report and Review of the Literature. J Endocr Soc. 2021 Jan 01; 5(1):bvaa165.
Monogenic Diabetes in a Child with Cystic Fibrosis: A Case Report and Review of the Literature.
Khan FN, Tangpricha V, Hughan KS, Jain R, Ladores SL, Taylor-Cousar JL, West NE, Montemayor K, Sawicki GS, Uluer A, Aitken ML, Shnorhavorian M, Bray LA, Kvam C, Stalvey M, Kazmerski TM
Men's health in the modern era of cystic fibrosis. J Cyst Fibros. 2021 11; 20(6):e121-e123.
Men's health in the modern era of cystic fibrosis.
Tribulations and (clinical) trials in cystic fibrosis. J Cyst Fibros. 2021 03; 20(2):188-190.
Tribulations and (clinical) trials in cystic fibrosis.
Mayer-Hamblett N, Nichols DP, Odem-Davis K, Riekert KA, Sawicki GS, Donaldson SH, Ratjen F, Konstan MW, Simon N, Rosenbluth DB, Retsch-Bogart G, Clancy JP, VanDalfsen JM, Buckingham R, Gifford AH
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design. Ann Am Thorac Soc. 2021 08; 18(8):1397-1405.
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.
Kawai K, Dombrowski N, Sawicki GS, Adil EA
Improvement of Pulmonary Function in Cystic Fibrosis Patients following Endoscopic Sinus Surgery. Laryngoscope. 2021 09; 131(9):1930-1938.
Improvement of Pulmonary Function in Cystic Fibrosis Patients following Endoscopic Sinus Surgery.
Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. Lancet Respir Med. 2021 07; 9(7):733-746.
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
An evaluation of healthcare utilization and clinical charges in children and adults with cystic fibrosis. Pediatr Pulmonol. 2021 05; 56(5):928-938.
An evaluation of healthcare utilization and clinical charges in children and adults with cystic fibrosis.
Davis J, Gordon R, Hammond A, Perkins R, Flanagan F, Rabinowitz E, Simoneau T, Sawicki GS
Rapid Implementation of Telehealth Services in a Pediatric Pulmonary Clinic During COVID-19. Pediatrics. 2021 07; 148(1).
Rapid Implementation of Telehealth Services in a Pediatric Pulmonary Clinic During COVID-19.
Perkins RC, Davis J, NeSmith A, Bailey J, Powers MR, Chaudary N, Siracusa C, Uluer A, Solomon GM, Sawicki GS
Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic. Ann Am Thorac Soc. 2021 09; 18(9):1588-1592.
Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.
Perkins RC, Gross R, Regan K, Bishay L, Sawicki GS
Perceptions of Social Media Use to Augment Health Care Among Adolescents and Young Adults With Cystic Fibrosis: Survey Study. JMIR Pediatr Parent. 2021 Aug 16; 4(3):e25014.
Perceptions of Social Media Use to Augment Health Care Among Adolescents and Young Adults With Cystic Fibrosis: Survey Study.
Sawicki GS, Van Brunt K, Booth J, Bailey E, Millar SJ, Konstan MW, Flume PA
Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation. J Cyst Fibros. 2022 01; 21(1):96-103.
Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
Shaffer LR, McCormack E, Sawicki GS, Keller A, Jain R
Understanding the Intersection between Gender Transition and Health Outcomes in Cystic Fibrosis. Ann Am Thorac Soc. 2022 03; 19(3):504-506.
Understanding the Intersection between Gender Transition and Health Outcomes in Cystic Fibrosis.
Scully KJ, Marchetti P, Sawicki GS, Uluer A, Cernadas M, Cagnina RE, Kennedy JC, Putman MS
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis. J Cyst Fibros. 2022 03; 21(2):258-263.
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis.
Virgin FW, Thurm C, Sanders DB, Freeman AJ, Cogen J, Gamel B, Sawicki G, Fink AK
Prevalence, variability, and predictors of sinus surgery in pediatric patients with cystic fibrosis. Pediatr Pulmonol. 2021 12; 56(12):4029-4038.
Prevalence, variability, and predictors of sinus surgery in pediatric patients with cystic fibrosis.
Scully KJ, Sherwood JS, Martin K, Ruazol M, Marchetti P, Larkin M, Zheng H, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Wexler DJ, Putman MS
Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis. J Clin Endocrinol Metab. 2022 03 24; 107(4):e1444-e1454.
Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
Sawicki GS, Van Citters AD, Dieni O, Sabadosa KA, Willis A, Benitez D, Ong T, Dasenbrook EC
Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future. J Cyst Fibros. 2021 12; 20 Suppl 3:16-20.
Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future.
Hart LC, Arvanitis M, Sawicki GS, Díaz-González de Ferris M, Zhang X, Long MD, Kappelman MD
Trajectories of the Transition Readiness Assessment Questionnaire Among Youth With Inflammatory Bowel Disease. J Clin Gastroenterol. 2022 10 01; 56(9):805-809.
Trajectories of the Transition Readiness Assessment Questionnaire Among Youth With Inflammatory Bowel Disease.
Solomon GM, Bailey J, Lawlor J, Scalia P, Sawicki GS, Dowd C, Sabadosa KA, Van Citters A
Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic. J Cyst Fibros. 2021 12; 20 Suppl 3:41-46.
Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic.
Ong T, Van Citters AD, Dowd C, Fullmer J, List R, Pai SA, Ren CL, Scalia P, Solomon GM, Sawicki GS
Remote monitoring in telehealth care delivery across the U.S. cystic fibrosis care network. J Cyst Fibros. 2021 12; 20 Suppl 3:57-63.
Remote monitoring in telehealth care delivery across the U.S. cystic fibrosis care network.
Gifford AH, Ong T, Dowd C, Van Citters AD, Scalia P, Sabadosa KA, Sawicki GS
Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs. J Cyst Fibros. 2021 12; 20 Suppl 3:9-13.
Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs.
Clarke AR, Stransky OM, Bernard M, Hughan KS, Ladores S, Sawicki GS, Stalvey M, Kazmerski TM
Exploring provider attitudes and perspectives related to men's health in cystic fibrosis. J Cyst Fibros. 2022 07; 21(4):652-656.
Exploring provider attitudes and perspectives related to men's health in cystic fibrosis.
Scully KJ, Jay LT, Freedman S, Sawicki GS, Uluer A, Finkelstein JS, Putman MS
The Relationship between Body Composition, Dietary Intake, Physical Activity, and Pulmonary Status in Adolescents and Adults with Cystic Fibrosis. Nutrients. 2022 Jan 12; 14(2).
The Relationship between Body Composition, Dietary Intake, Physical Activity, and Pulmonary Status in Adolescents and Adults with Cystic Fibrosis.
Stransky OM, Pam M, Ladores SL, Birru Talabi M, Borrero S, Godfrey EM, Roe AH, Sawicki GS, Zuckerwise LC, Mody S, Mentch L, Deal A, O'Leary R, Taylor-Cousar JL, Jain R, Kazmerski TM
Engaging Stakeholders in the Development of a Reproductive Goals Decision AID for Women with Cystic Fibrosis. J Patient Exp. 2022; 9:23743735221077527.
Engaging Stakeholders in the Development of a Reproductive Goals Decision AID for Women with Cystic Fibrosis.
Sawicki GS, Chilvers M, McNamara J, Naehrlich L, Saunders C, Sermet-Gaudelus I, Wainwright CE, Ahluwalia N, Campbell D, Harris RS, Paz-Diaz H, Shih JL, Davies JC
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children = 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant. J Cyst Fibros. 2022 07; 21(4):675-683.
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children = 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant.
Clarke AR, Stransky OM, Bernard M, Hughan KS, Ladores S, Sawicki GS, Stalvey MS, Kazmerski TM
Men's sexual and reproductive health in cystic fibrosis in the era of highly effective modulator therapies-A qualitative study. J Cyst Fibros. 2022 07; 21(4):657-661.
Men's sexual and reproductive health in cystic fibrosis in the era of highly effective modulator therapies-A qualitative study.
Author Reply to: Empowering Without Misinforming Adolescents and Young Adults with Cystic Fibrosis. Comment on "Perceptions of Social Media Use to Augment Health Care Among Adolescents and Young Adults With Cystic Fibrosis: Survey Study". JMIR Pediatr Parent. 2022 May 25; 5(2):e39450.
Author Reply to: Empowering Without Misinforming Adolescents and Young Adults with Cystic Fibrosis. Comment on "Perceptions of Social Media Use to Augment Health Care Among Adolescents and Young Adults With Cystic Fibrosis: Survey Study".
Kass AP, Berbert L, Dahlberg S, Bern E, Sabharwal S, Leonard J, Richmond T, Sawicki GS
Eating disorders in adolescents and young adults with cystic fibrosis. Pediatr Pulmonol. 2022 11; 57(11):2791-2797.
Eating disorders in adolescents and young adults with cystic fibrosis.
Kazmerski TM, Stransky OM, Lavage DR, Taylor-Cousar JL, Sawicki GS, Ladores SL, Godfrey EM, Aitken ML, Fields A, Sufian S, Jain M, Barto TL, Billings J, Hadjiliadis D, Jain R
Sexual and reproductive health experiences and care of adult women with cystic fibrosis. J Cyst Fibros. 2023 03; 22(2):223-233.
Sexual and reproductive health experiences and care of adult women with cystic fibrosis.
Davis J, Ryan M, Marchetti P, Dahlberg SE, Greenberg J, Bacon C, Kaur R, Scalia S, Sawicki GS
Real-world feasibility of short-term, unsupervised home spirometry in CF. Pediatr Pulmonol. 2022 12; 57(12):3129-3135.
Real-world feasibility of short-term, unsupervised home spirometry in CF.
Sawicki GS, Konstan MW, McKone EF, Moss RB, Lubarsky B, Suthoff E, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan WJ, Duncan ME, Yang Y
Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation. Pulm Ther. 2022 Dec; 8(4):385-395.
Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation.
Baker AM, Riekert KA, Sawicki GS, Eakin MN
Pediatric allergy, immunology, and pulmonology
CF RISE: Implementing a Clinic-Based Transition Program. Pediatr Allergy Immunol Pulmonol. 2015 Dec; 28(4):250-254.
CF RISE: Implementing a Clinic-Based Transition Program.
Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Lancet Respir Med. 2023 04; 11(4):329-340.
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
Kass AP, Kazmerski TM, Bern E, Sabharwal S, Leonard J, Harrison M, Barnico K, Richmond T, Sawicki GS
Clinician perspectives on assessing for disordered eating and body image disturbance in adolescents and young adults with cystic fibrosis. J Cyst Fibros. 2023 May; 22(3):431-435.
Clinician perspectives on assessing for disordered eating and body image disturbance in adolescents and young adults with cystic fibrosis.
Lee T, Sawicki GS, Altenburg J, Millar SJ, Geiger JM, Jennings MT, Lou Y, McGarry LJ, Van Brunt K, Linnemann RW
EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS. J Cyst Fibros. 2023 May; 22(3):402-406.
EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS.
Flume PA, Harris RS, Paz-Diaz H, Ahluwalia N, Higgins M, Campbell D, Berhane I, Shih JL, Sawicki G
Long-term tezacaftor/ivacaftor safety and efficacy in people with cystic fibrosis and an F508del-CFTR mutation: 96-week, open-label extension of the EXTEND trial. J Cyst Fibros. 2023 May; 22(3):464-470.
Long-term tezacaftor/ivacaftor safety and efficacy in people with cystic fibrosis and an F508del-CFTR mutation: 96-week, open-label extension of the EXTEND trial.
McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT
How many billions is enough? Prioritizing profits over patients with cystic fibrosis. Pediatr Pulmonol. 2023 05; 58(5):1595-1597.
How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
High deductible insurance plans impart economic burden for people with cystic fibrosis. Pediatr Pulmonol. 2023 06; 58(6):1798-1801.
High deductible insurance plans impart economic burden for people with cystic fibrosis.
Perturbing the muscle work loop paradigm to unravel the neuromechanics of unsteady locomotion. J Exp Biol. 2023 04 01; 226(7).
Perturbing the muscle work loop paradigm to unravel the neuromechanics of unsteady locomotion.
Abbott EM, Stephens JD, Simha SN, Wood L, Nardelli P, Cope TC, Sawicki GS, Ting LH
bioRxiv : the preprint server for biology
Attenuation of muscle spindle firing with artificially increased series compliance during stretch of relaxed muscle. bioRxiv. 2023 May 09.
Attenuation of muscle spindle firing with artificially increased series compliance during stretch of relaxed muscle.
McCain EM, Dalman MJ, Berno ME, Libera TL, Lewek MD, Sawicki GS, Saul KR
The influence of induced gait asymmetry on joint reaction forces. J Biomech. 2023 05; 153:111581.
The influence of induced gait asymmetry on joint reaction forces.
Sawicki GS, Goodman A, Bacon C, Collins L, Greenberg J, Duncan C, Frederick C, Luebbert S, Mazuera S, Polineni D, Stark LL, George C, Riekert KA
Partners in research: The success with therapies research consortium and the CF community unite to improve self-management. J Cyst Fibros. 2023 09; 22(5):830-835.
Partners in research: The success with therapies research consortium and the CF community unite to improve self-management.
Funk CJ, Krupenevich RL, Sawicki GS, Franz JR
American Society of Biomechanics Journal of Biomechanics Award 2021: Exploring the Functional Boundaries and Metabolic Consequences of Triceps Surae Force-Length Relations during Walking. J Biomech. 2023 09; 158:111771.
American Society of Biomechanics Journal of Biomechanics Award 2021: Exploring the Functional Boundaries and Metabolic Consequences of Triceps Surae Force-Length Relations during Walking.
Simulations suggest walking with reduced propulsive force would not mitigate the energetic consequences of lower tendon stiffness. PLoS One. 2023; 18(10):e0293331.
Simulations suggest walking with reduced propulsive force would not mitigate the energetic consequences of lower tendon stiffness.
Attenuation of muscle spindle firing with artificially increased series compliance during stretch of relaxed muscle. Exp Physiol. 2024 01; 109(1):148-158.
Sherwood JS, Castellanos LE, O'Connor MY, Balliro CA, Hillard MA, Gaston SG, Bartholomew R, Greaux E, Sabean A, Zheng H, Marchetti P, Uluer A, Sawicki GS, Neuringer I, El-Khatib FH, Damiano ER, Russell SJ, Putman MS
Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes. Diabetes Care. 2024 01 01; 47(1):101-108.
Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.
IEEE ... International Conference on Rehabilitation Robotics : [proceedings]
Predictive Control of Peak Achilles Tendon Force in a Simulated System of the Human Ankle Joint with a Parallel Artificial Actuator During Hopping. IEEE Int Conf Rehabil Robot. 2023 09; 2023:1-6.
Predictive Control of Peak Achilles Tendon Force in a Simulated System of the Human Ankle Joint with a Parallel Artificial Actuator During Hopping.
Kazmerski TM, Stransky OM, Lavage DR, Hughan KS, Jain R, Ladores SL, Stalvey MS, Tangpricha V, Taylor-Cousar JL, West NE, Sawicki GS
Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis. J Cyst Fibros. 2024 May; 23(3):417-423.
Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis.
Franz JR, Krupenevich RL, Gray AJ, Batsis JA, Sawicki GS
Reduced Achilles tendon stiffness in aging persists at matched activations and associates with higher metabolic cost of walking. bioRxiv. 2023 Nov 27.
Reduced Achilles tendon stiffness in aging persists at matched activations and associates with higher metabolic cost of walking.
Sawicki GS, Wicha WW, Hiley TS, Close NC, Gelone SP, Guico-Pabia CJ
Safety and Pharmacokinetics Following Oral or Intravenous Lefamulin in Adults With Cystic Fibrosis. Clin Ther. 2024 02; 46(2):96-103.
Safety and Pharmacokinetics Following Oral or Intravenous Lefamulin in Adults With Cystic Fibrosis.
Journal of applied physiology (Bethesda, Md. : 1985)
Habitually wearing high heels may improve user walking economy in any footwear. J Appl Physiol (1985). 2024 Mar 01; 136(3):567-572.
Habitually wearing high heels may improve user walking economy in any footwear.
Dickinson KM, Smith BM, Green DM, Nasr S, Sawicki GS, Schechter MS, Riekert KA
An emotional journey: caregiver experiences with gastrostomy tube decision-making for children with cystic fibrosis. J Cyst Fibros. 2024 Sep; 23(5):1000-1006.
An emotional journey: caregiver experiences with gastrostomy tube decision-making for children with cystic fibrosis.
Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS
Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF. Front Endocrinol (Lausanne). 2024; 15:1293709.
Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Leestma JK, Smith CR, Sawicki GS, Young AJ
A Data-Driven Approach to Estimate Human Center of Mass State During Perturbed Locomotion Using Simulated Wearable Sensors. Ann Biomed Eng. 2024 Aug; 52(8):2013-2023.
A Data-Driven Approach to Estimate Human Center of Mass State During Perturbed Locomotion Using Simulated Wearable Sensors.
Smith RE, Shelton AD, Sawicki GS, Franz JR
The effects of plantarflexor weakness and reduced tendon stiffness with aging on gait stability. PLoS One. 2024; 19(4):e0302021.
The effects of plantarflexor weakness and reduced tendon stiffness with aging on gait stability.
Eaton CK, McWilliams E, Yablon D, Kesim I, Ge R, Mirus K, Sconiers T, Donkoh A, Lawrence M, George C, Morrison ML, Muther E, Oates GR, Sathe M, Sawicki GS, Snell C, Riekert K
Cross-Cutting mHealth Behavior Change Techniques to Support Treatment Adherence and Self-Management of Complex Medical Conditions: Systematic Review. JMIR Mhealth Uhealth. 2024 May 01; 12:e49024.
Cross-Cutting mHealth Behavior Change Techniques to Support Treatment Adherence and Self-Management of Complex Medical Conditions: Systematic Review.
Phan H, Daines CL, Woo T, Psoter KJ, Goodman A, McWilliams E, Frederick C, Milla C, Oates G, Sawicki GS, Riekert KA
Development and preliminary validation of the personalized cystic fibrosis medication questionnaire (PCF-MQ). J Cyst Fibros. 2024 Nov; 23(6):1100-1105.
Development and preliminary validation of the personalized cystic fibrosis medication questionnaire (PCF-MQ).
Advances in Care and Outcomes for Children with Cystic Fibrosis. Clin Chest Med. 2024 Sep; 45(3):625-637.
Advances in Care and Outcomes for Children with Cystic Fibrosis.
Overview and Updates in Pediatric Pulmonary Medicine. Clin Chest Med. 2024 Sep; 45(3):xiii-xiv.
Overview and Updates in Pediatric Pulmonary Medicine.
Mayer-Hamblett N, Gifford AH, Kloster M, Russell R, Braun AT, Gibson RL, Hoppe JE, Jain R, Linnemann RW, Liou TG, Lysinger J, Milla C, Riekert KA, Sawicki GS, Young J, Nichols D
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis. Ann Am Thorac Soc. 2024 Nov; 21(11):1507-1515.
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.
Jakubowski KL, Martino G, Beck ON, Sawicki GS, Ting LH
Center of mass states render multi-joint torques throughout standing balance recovery. bioRxiv. 2024 Aug 19.
Center of mass states render multi-joint torques throughout standing balance recovery.
Claim-based analyses of inhaled corticosteroid refill rates for asthma: who's kidding whom? Ann Am Thorac Soc. 2013 Apr; 10(2):149-50.
Claim-based analyses of inhaled corticosteroid refill rates for asthma: who's kidding whom?
Gifford AH, Odem-Davis K, Kloster M, O'Sullivan BP, Omlor GJ, Millard SL, Clancy JP, Sawicki GS, Riekert K, Mayer-Hamblett N, Nichols DP
Self-reported chronic therapy use after 24-weeks of follow-up by participants who completed the simplify randomized, controlled trial. J Cyst Fibros. 2025 Jan; 24(1):91-97.
Self-reported chronic therapy use after 24-weeks of follow-up by participants who completed the simplify randomized, controlled trial.
Scully KJ, Truex L, Brennan A, Fowler R, Sawicki GS, Uluer A, Ludwig DS, Ebbeling CB, Langlais L, Dziok A, Freedman SD, Putman MS
Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study. Front Nutr. 2024; 11:1441201.
Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study.
Hergenroeder GE, Todd JV, Ostrenga JS, Goss CH, Jain R, Morgan W, Sawicki GS, Schechter MS, Cromwell EA, Ren CL
Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele. J Cyst Fibros. 2025 Jan; 24(1):135-141.
Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele.
Everhart RS, McWilliams E, Maggs J, Sawicki GS, Sconiers T, Smith K, Yablon D, Butcher J, Prickett M, Bacon C, Goodman A, Gifford AH, Mayer-Hamblett N, Nichols DP, Riekert KA
What does it mean to be "healthy" when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study. J Cyst Fibros. 2025 Jan; 24(1):187-192.
What does it mean to be "healthy" when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study.
Wasserman MG, Greenberg J, Hall B, Staffa SJ, Sawicki GS, Priebe GP
Plasma Microbial Cell-Free DNA Metagenomic Next-Generation Sequencing in People With Cystic Fibrosis. Pediatr Pulmonol. 2025 Jan; 60(1):e27380.
Plasma Microbial Cell-Free DNA Metagenomic Next-Generation Sequencing in People With Cystic Fibrosis.
Maggs J, Sawicki GS, Bacon C, McWilliams E, Yablon D, Ertman B, Sweeney L, Butcher JL, Everhart RS, Prickett M, Siracusa C, Gifford AH, Mayer-Hamblett N, Nichols DP, Goodman A, Woo T, Riekert KA
Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study. Contemp Clin Trials. 2025 Jan; 148:107752.
Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study.
Gray AJ, Krupenevich RL, Batsis JA, Sawicki GS, Franz JR
Reduced Achilles tendon stiffness in aging associates with higher metabolic cost of walking. J Appl Physiol (1985). 2024 Dec 01; 137(6):1541-1548.
Reduced Achilles tendon stiffness in aging associates with higher metabolic cost of walking.
Davenport FR, Leestma JK, Staten A, Bhakta K, Fernandez J, Mazumdar A, Young AJ, Sawicki GS
Electromyography-Informed Estimates of Joint Contact Forces Within the Lower Back and Knee Joints During a Diverse Set of Industry-Relevant Manual Lifting Tasks. J Appl Biomech. 2025 Apr 01; 41(2):151-160.
Electromyography-Informed Estimates of Joint Contact Forces Within the Lower Back and Knee Joints During a Diverse Set of Industry-Relevant Manual Lifting Tasks.
Center of mass states render multijoint torques throughout standing balance recovery. J Neurophysiol. 2025 Jan 01; 133(1):206-221.
Center of mass states render multijoint torques throughout standing balance recovery.
Colborg A, Smith BM, Green DM, Nasr S, Sawicki GS, Schechter MS, Riekert KA, Dickinson KM
"It's Like You're Feeding Your Child Twice": Barriers and Facilitators to Human Milk Feeding Children With Cystic Fibrosis. Pediatr Pulmonol. 2025 Jan; 60(1):e27497.
"It's Like You're Feeding Your Child Twice": Barriers and Facilitators to Human Milk Feeding Children With Cystic Fibrosis.
Dill EJ, Dawson R, Sellers DE, Robinson WM, Sawicki GS
Longitudinal trends in health-related quality of life in adults with cystic fibrosis. Chest. 2013 Sep; 144(3):981-989.
Longitudinal trends in health-related quality of life in adults with cystic fibrosis.
Brady E, Perkins RC, Cullen K, Sawicki GS, Kaplan RS, Doyle G
NEJM catalyst innovations in care delivery
Innovations in Evaluating Ambulatory Costs of Cystic Fibrosis Care: A Comparative Study Across Multidisciplinary Care Centers in Ireland and the United States. NEJM Catal Innov Care Deliv. 2025 Feb; 6(2).
Innovations in Evaluating Ambulatory Costs of Cystic Fibrosis Care: A Comparative Study Across Multidisciplinary Care Centers in Ireland and the United States.
Davis J, Perkins R, Bailey J, Chaudary N, Garcia B, Froh D, Powers M, Siracusa C, Sawicki GS
Acceptability of Telehealth Post-Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis. Pediatr Pulmonol. 2025 Feb; 60(2):e70000.
Acceptability of Telehealth Post-Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis.
Leestma JK, Mathur S, Anderton MD, Sawicki GS, Young AJ
Dynamic Duo: Design and Validation of an Autonomous Frontal and Sagittal Actuating Hip Exoskeleton for Balance Modulation During Perturbed Locomotion. IEEE Robot Autom Lett. 2024 May; 9(5):3995-4002.
Dynamic Duo: Design and Validation of an Autonomous Frontal and Sagittal Actuating Hip Exoskeleton for Balance Modulation During Perturbed Locomotion.
Prangley KA, Stransky OM, Burke JG, Ladores SL, Hughan KS, Sawicki GS, Kazmerski TM
Male sexual and reproductive health in cystic fibrosis: A concept mapping study. J Cyst Fibros. 2025 May; 24(3):484-490.
Male sexual and reproductive health in cystic fibrosis: A concept mapping study.
Daines CL, Polineni D, Tullis E, Costa S, Linnemann RW, Mall MA, McKone EF, Quon BS, Ringshausen FC, Selvadurai H, Taylor-Cousar JL, Withers NJ, Sawicki GS, Lee T, Ahluwalia N, Morlando Geiger J, Jennings M, Tan YV, Waltz D, Ramsey B, Griese M
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3 Open-Label Extension Study. Am J Respir Crit Care Med. 2025 10; 211(10):1901-1914.
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3 Open-Label Extension Study.
Albon D, Ong T, Horton B, Brighton D, Shen S, List R, Antos N, Asfour F, Balasa E, Beachler D, Daines C, Froh D, Kier C, Nasr S, Sathe M, Sawicki G, Schechter M, Solomon G, Powers M
Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID-19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model. Pediatr Pulmonol. 2025 May; 60(5):e71102.
Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID-19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model.
Predictive control of musculotendon loads across fast and slow-twitch muscles in a simulated system with parallel actuation. Wearable Technol. 2025; 6:e8.
Predictive control of musculotendon loads across fast and slow-twitch muscles in a simulated system with parallel actuation.
Huang L, Lai HJ, Furuya KN, Antos NJ, Asfour F, Boyne KL, Howenstine M, Rock MJ, Sawicki GS, Gaffin JM, Worthey EA, Farrell PM
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis. Pediatr Pulmonol. 2025 Mar; 60(3):e71042.
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis.
The effects of series elastic stiffness and cutaneous sensitivity on leg muscle reflex responses to unanticipated slips during walking. Exp Brain Res. 2025 May 20; 243(6):150.
The effects of series elastic stiffness and cutaneous sensitivity on leg muscle reflex responses to unanticipated slips during walking.
Cleveland RH, Stamoulis C, Sawicki G, Kelliher E, Zucker EJ, Wood C, Zurakowski D, Lee E
Brasfield and Wisconsin scoring systems have equal value as outcome assessment tools of cystic fibrosis lung disease. Pediatr Radiol. 2014 May; 44(5):529-34.
Brasfield and Wisconsin scoring systems have equal value as outcome assessment tools of cystic fibrosis lung disease.
Davis J, Gibson SL, Perkins RC, Greenberg J, Simoneau T, Sawicki GS
Perceptions of Telehealth in Pediatric Pulmonary Clinic Post-Pandemic. Pediatr Pulmonol. 2025 Aug; 60(8):e71237.
Perceptions of Telehealth in Pediatric Pulmonary Clinic Post-Pandemic.
Simoneau T, Bazzaz O, Sawicki GS, Gordon C
Vitamin D status in children with cystic fibrosis. Associations with inflammation and bacterial colonization. Ann Am Thorac Soc. 2014 Feb; 11(2):205-10.
Vitamin D status in children with cystic fibrosis. Associations with inflammation and bacterial colonization.
Sawicki GS, Heller KS, Demars N, Robinson WM
Motivating adherence among adolescents with cystic fibrosis: youth and parent perspectives. Pediatr Pulmonol. 2015 Feb; 50(2):127-36.
Motivating adherence among adolescents with cystic fibrosis: youth and parent perspectives.
Virgin FW, Huang L, Roberson DW, Sawicki GS
Inter-hospital variation in the frequency of sinus surgery in children with cystic fibrosis. Pediatr Pulmonol. 2015 Mar; 50(3):231-235.
Inter-hospital variation in the frequency of sinus surgery in children with cystic fibrosis.
Sharma N, O'Hare K, Antonelli RC, Sawicki GS
Transition care: future directions in education, health policy, and outcomes research. Acad Pediatr. 2014 Mar-Apr; 14(2):120-7.
Transition care: future directions in education, health policy, and outcomes research.
Fernandes SM, O'Sullivan-Oliveira J, Landzberg MJ, Khairy P, Melvin P, Sawicki GS, Ziniel S, Kenney LB, Garvey KC, Sobota A, O'Brien R, Nigrovic PA, Sharma N, Fishman LN
Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective. J Pediatr Rehabil Med. 2014; 7(1):43-51.
Transition and transfer of adolescents and young adults with pediatric onset chronic disease: the patient and parent perspective.
Melton K, Fried K, Stotsky M, O'Donnell S, Connor JA, Sawicki G
"My friends make it feel like I'm the same": A qualitative study of psychosocial and peer factors in adolescent self-management of chronic conditions. J Pediatr Nurs. 2025 Nov-Dec; 85:75-82.
"My friends make it feel like I'm the same": A qualitative study of psychosocial and peer factors in adolescent self-management of chronic conditions.
Kazmerski TM, Stransky OM, Wright CE, Jathal I, Prangley A, Tangpricha V, Jain R, Barrett SL, Hughan KS, West NE, Taylor-Cousar JL, Sawicki GS
Sexual health experiences and care utilization of males with cystic fibrosis. J Cyst Fibros. 2026 Jan; 25(1):92-97.
Sexual health experiences and care utilization of males with cystic fibrosis.
Jathal I, Stransky OM, Wright CE, Prangley A, Tangpricha V, Jain R, Taylor-Cousar JL, Hughan KS, Ladores-Barrett S, West NE, Sawicki GS, Kazmerski TM
Reproductive biology and endocrinology : RB&E
Fertility and family-building experiences and perspectives of males with cystic fibrosis. Reprod Biol Endocrinol. 2025 Jun 02; 23(1):85.
Fertility and family-building experiences and perspectives of males with cystic fibrosis.
Golyski PR, Swaich NK, Panizzolo FA, Sawicki GS
Erratum to "Effects of an elastic hip exoskeleton on stability quantified by mechanical energetics and whole-body angular momentum during walking with treadmill belt speed perturbations". [J. Biomech. 188 (2025) 112784]. J Biomech. 2025 Oct; 191:112869.
Erratum to "Effects of an elastic hip exoskeleton on stability quantified by mechanical energetics and whole-body angular momentum during walking with treadmill belt speed perturbations". [J. Biomech. 188 (2025) 112784].
Butcher JL, Siracusa C, Grabowski H, Yablon D, Ertman B, McWilliams E, Woo T, Everhart RS, Maggs J, Prickett M, Gifford AH, Mayer-Hamblett N, Nichols DP, Riekert KA, Sawicki GS
"Time out for an hour, every day, my whole life": understanding treatment burden in cystic fibrosis in the era of Elexacaftor/Tezacaftor/Ivacaftor (ETI). J Cyst Fibros. 2025 Nov; 24(6):1130-1140.
"Time out for an hour, every day, my whole life": understanding treatment burden in cystic fibrosis in the era of Elexacaftor/Tezacaftor/Ivacaftor (ETI).
Hale JE, O'Sullivan BP, Parad RB, Dorkin HL, Kremer TM, Vehse NW, Yonker LM, Sawicki GS, Counihan AM, Gerstel-Thompson J, Kumar B, Comeau AM
Genetics in medicine : official journal of the American College of Medical Genetics
Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis. Genet Med. 2026 Jan; 28(1):101629.
Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis.
Sarrieddine A, Lai C, Walk OBD, Reid NFH, Sawicki G, Berlinski A, Rosenfeld M, Hartzler AL
AMIA ... Annual Symposium proceedings. AMIA Symposium
Technology and Human Support Systems in Decentralized Studies: A Participant-Centered Case Study in Cystic Fibrosis. AMIA Annu Symp Proc. 2024; 2024:1130-1139.
Technology and Human Support Systems in Decentralized Studies: A Participant-Centered Case Study in Cystic Fibrosis.
Alshareef AA, Nardelli P, Simha SN, Cope TC, Ting LH, Sawicki GS
Influence of exoskeleton stiffness on primary afferent feedback during stretch perturbations of isolated muscle-tendon unit. bioRxiv. 2025 Nov 05.
Influence of exoskeleton stiffness on primary afferent feedback during stretch perturbations of isolated muscle-tendon unit.
Maggs J, Sweeney L, Pucci A, McWilliams E, Yablon D, Ertman B, Butcher JL, Everhart RS, Siracusa C, Gifford AH, Mayer-Hamblett N, Bacon C, Goodman A, Woo T, Riekert KA, Sawicki GS, Prickett M
Developing a framework for clinical conversations using a qualitative analysis of the patient experience of SIMPLIFY. Patient Educ Couns. 2025 Sep; 138:109183.
Developing a framework for clinical conversations using a qualitative analysis of the patient experience of SIMPLIFY.
Herrin KR, Pan YT, Kesar TM, Sawicki GS, Young AJ
Robotic Ankle Exoskeleton and Limb Angle Biofeedback for Assisting Stroke Gait: A Feasibility Study. IEEE Robot Autom Lett. 2025 Feb; 10(2):1011-1017.
Robotic Ankle Exoskeleton and Limb Angle Biofeedback for Assisting Stroke Gait: A Feasibility Study.
Kazmerski TM, Kidd KM, Jain R, Jathal I, Stransky OM, Lee M, Salyer RE, Tangpricha V, Palla J, Alpern AN, Lunn MR, Obedin-Maliver J, Greenberg J, Prangley A, Sawicki GS
Investigating the Interplay Between Having Cystic Fibrosis and Being a Member of the LGBTQIA+ Community: Protocol for the PRIDE CF Study. Pediatr Pulmonol. 2025 Jun; 60(6):e71154.
Investigating the Interplay Between Having Cystic Fibrosis and Being a Member of the LGBTQIA+ Community: Protocol for the PRIDE CF Study.
Effects of an elastic hip exoskeleton on stability quantified by mechanical energetics and whole-body angular momentum during walking with treadmill belt speed perturbations. J Biomech. 2025 Jul; 188:112784.
Effects of an elastic hip exoskeleton on stability quantified by mechanical energetics and whole-body angular momentum during walking with treadmill belt speed perturbations.
The effects of soleus fascicle length on muscle fatigability. PeerJ. 2025; 13:e19842.
The effects of soleus fascicle length on muscle fatigability.
Casey RTF, Nuesslein CPO, Davenport F, Wheeler J, Mazumdar A, Sawicki G, Young AJ
IEEE transactions on bio-medical engineering
The Second Skin: A Wearable Sensor Suite That Enables Real-Time Human Biomechanics Tracking Through Deep Learning. IEEE Trans Biomed Eng. 2026 Feb; 73(2):621-630.
The Second Skin: A Wearable Sensor Suite That Enables Real-Time Human Biomechanics Tracking Through Deep Learning.
Thompson SA, Foley EE, Franz JR, Sawicki GS, Lewek MD
Pairing limb posture feedback with an ankle exoskeleton to augment limb propulsion. PLoS One. 2025; 20(10):e0335054.
Pairing limb posture feedback with an ankle exoskeleton to augment limb propulsion.
Bailey J, Jennings D, Alao M, Anderson JD, Garcia B, Gordon R, Gravley K, Harrison M, Powers M, Prettiman S, Salter N, Sawicki GS, Albon D
Therapeutic advances in respiratory disease
Remotely addressing health-related social needs (ELICIT) in cystic fibrosis: design and implementation of a multicenter screening and intervention quality improvement project. Ther Adv Respir Dis. 2025 Jan-Dec; 19:17534666251393088.
Remotely addressing health-related social needs (ELICIT) in cystic fibrosis: design and implementation of a multicenter screening and intervention quality improvement project.
Snell CJ, Ryan ME, Bailey IV, Sandage D, Ertman B, Dahlberg S, Alpern AN, Smith B, Garcia B, Ito E, Sawicki G, Uluer A
Development of the Cystic Fibrosis Stress Questionnaire: testing and validation. BMJ Open Respir Res. 2025 Dec 03; 12(1).
Development of the Cystic Fibrosis Stress Questionnaire: testing and validation.
Wood DL, Sawicki GS, Miller MD, Smotherman C, Lukens-Bull K, Livingood WC, Ferris M, Kraemer DF
The Transition Readiness Assessment Questionnaire (TRAQ): its factor structure, reliability, and validity. Acad Pediatr. 2014 Jul-Aug; 14(4):415-22.
The Transition Readiness Assessment Questionnaire (TRAQ): its factor structure, reliability, and validity.
Ready, set, stop: mismatch between self-care beliefs, transition readiness skills, and transition planning among adolescents, young adults, and parents. Clin Pediatr (Phila). 2014 Oct; 53(11):1062-8.
Ready, set, stop: mismatch between self-care beliefs, transition readiness skills, and transition planning among adolescents, young adults, and parents.
Putman MS, Milliren CE, Derrico N, Uluer A, Sicilian L, Lapey A, Sawicki G, Gordon CM, Bouxsein ML, Finkelstein JS
Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis. J Clin Endocrinol Metab. 2014 Sep; 99(9):3399-407.
Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis.
Schechter MS, Regelmann WE, Sawicki GS, Rasouliyan L, VanDevanter DR, Rosenfeld M, Pasta D, Morgan W, Konstan MW
Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site. Pediatr Pulmonol. 2015 May; 50(5):431-40.
Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.
Wisk LE, Finkelstein JA, Sawicki GS, Lakoma M, Toomey SL, Schuster MA, Galbraith AA
Predictors of timing of transfer from pediatric- to adult-focused primary care. JAMA Pediatr. 2015 Jun; 169(6):e150951.
Predictors of timing of transfer from pediatric- to adult-focused primary care.
Sawicki GS, Dasenbrook E, Fink AK, Schechter MS
Rate of Uptake of Ivacaftor Use after U.S. Food and Drug Administration Approval among Patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry. Ann Am Thorac Soc. 2015 Aug; 12(8):1146-52.
Rate of Uptake of Ivacaftor Use after U.S. Food and Drug Administration Approval among Patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry.
Linnemann RW, O'Malley PJ, Friedman D, Georgiopoulos AM, Buxton D, Altstein LL, Sicilian L, Lapey A, Sawicki GS, Moskowitz SM
Development and evaluation of a palliative care curriculum for cystic fibrosis healthcare providers. J Cyst Fibros. 2016 Jan; 15(1):90-5.
Development and evaluation of a palliative care curriculum for cystic fibrosis healthcare providers.
Similar performance of Brasfield and Wisconsin scoring systems in young children with cystic fibrosis. Pediatr Radiol. 2015 Oct; 45(11):1624-8.
Similar performance of Brasfield and Wisconsin scoring systems in young children with cystic fibrosis.
Sawicki GS, Chou W, Raimundo K, Trzaskoma B, Konstan MW
Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients. J Cyst Fibros. 2015 Nov; 14(6):777-83.
Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients.
Simoneau T, Sawicki GS, Milliren CE, Feldman HA, Gordon CM
A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients. J Cyst Fibros. 2016 Mar; 15(2):234-41.
A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
Sawicki GS, McKone EF, Pasta DJ, Millar SJ, Wagener JS, Johnson CA, Konstan MW
Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data. Am J Respir Crit Care Med. 2015 Oct 01; 192(7):836-42.
Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data.
Sawicki GS, Garvey KC, Toomey SL, Williams KA, Chen Y, Hargraves JL, Leblanc J, Schuster MA, Finkelstein JA
The Journal of adolescent health : official publication of the Society for Adolescent Medicine
Development and Validation of the Adolescent Assessment of Preparation for Transition: A Novel Patient Experience Measure. J Adolesc Health. 2015 Sep; 57(3):282-7.
Development and Validation of the Adolescent Assessment of Preparation for Transition: A Novel Patient Experience Measure.
Tackling the increasing complexity of CF care. Pediatr Pulmonol. 2015 Oct; 50 Suppl 40:S74-9.
Tackling the increasing complexity of CF care.
Cohen SE, Hooper SR, Javalkar K, Haberman C, Fenton N, Lai H, Mahan JD, Massengill S, Kelly M, Cantú G, Medeiros M, Phillips A, Sawicki G, Wood D, Johnson M, Benton MH, Ferris M
Self-Management and Transition Readiness Assessment: Concurrent, Predictive and Discriminant Validation of the STARx Questionnaire. J Pediatr Nurs. 2015 Sep-Oct; 30(5):668-76.
Self-Management and Transition Readiness Assessment: Concurrent, Predictive and Discriminant Validation of the STARx Questionnaire.
Sanders DB, Fink A, Mayer-Hamblett N, Schechter MS, Sawicki GS, Rosenfeld M, Flume PA, Morgan WJ
Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years. J Pediatr. 2015 Nov; 167(5):1081-8.e1.
Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.
Future Investigators: A research education partnership between Uphams Corner Charter School and Harvard Medical School
Future Investigators: Uphams Corner Charter School
Davies JC, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Robertson S, Green Y, Cooke J, Rosenfeld M
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. Lancet Respir Med. 2016 Feb; 4(2):107-15.
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study.
Tarshish Y, Huang L, Jackson FI, Edwards J, Fligor B, Wilkins A, Uluer A, Sawicki G, Kenna M
Journal of the American Academy of Audiology
Risk Factors for Hearing Loss in Patients with Cystic Fibrosis. J Am Acad Audiol. 2016 01; 27(1):6-12.
Risk Factors for Hearing Loss in Patients with Cystic Fibrosis.
Future Investigators: A research education partnership between Upham’s Corner Charter School and Harvard Medical School
Putman MS, Greenblatt LB, Sicilian L, Uluer A, Lapey A, Sawicki G, Gordon CM, Bouxsein ML, Finkelstein JS
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis. Osteoporos Int. 2016 08; 27(8):2497-505.
Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis.
Suthoff ED, Bonafede M, Limone B, O'Callaghan L, Sawicki GS, Wagener JS
Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis. J Med Econ. 2016 Sep; 19(9):845-51.
Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis.
Cystic Fibrosis as a Model of Health Care Transition for Chronically Ill Youth
Kenney LB, Melvin P, Fishman LN, O'Sullivan-Oliveira J, Sawicki GS, Ziniel S, Diller L, Fernandes SM
Transition and transfer of childhood cancer survivors to adult care: A national survey of pediatric oncologists. Pediatr Blood Cancer. 2017 02; 64(2):346-352.
Transition and transfer of childhood cancer survivors to adult care: A national survey of pediatric oncologists.
Forno E, Weiner DJ, Mullen J, Sawicki G, Kurland G, Han YY, Cloutier MM, Canino G, Weiss ST, Litonjua AA, Celedón JC
Obesity and Airway Dysanapsis in Children with and without Asthma. Am J Respir Crit Care Med. 2017 Feb 01; 195(3):314-323.
Obesity and Airway Dysanapsis in Children with and without Asthma.
Aqul A, Jonas MM, Harney S, Raza R, Sawicki GS, Mitchell PD, Fawaz R
Journal of pediatric gastroenterology and nutrition
Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease. J Pediatr Gastroenterol Nutr. 2017 04; 64(4):505-511.
Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease.
Greenberg J, Palmer JB, Chan WW, Correia CE, Whalley D, Shannon P, Sawicki GS
Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder. Patient Prefer Adherence. 2016; 10:2163-2169.
Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder.
Adolescent health, medicine and therapeutics
Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis. Adolesc Health Med Ther. 2016; 7:117-124.
Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis.
Konstan MW, McKone EF, Moss RB, Marigowda G, Tian S, Waltz D, Huang X, Lubarsky B, Rubin J, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan W, Sawicki GS
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study. Lancet Respir Med. 2017 02; 5(2):107-118.
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.
Reply: Combining Clinical Trial and Patient Registry Data in Cystic Fibrosis: Who Should Be Compared? Am J Respir Crit Care Med. 2017 02 01; 195(3):405-406.
Reply: Combining Clinical Trial and Patient Registry Data in Cystic Fibrosis: Who Should Be Compared?
Kazmerski TM, Borrero S, Sawicki GS, Abebe KZ, Jones KA, Tuchman LK, Weiner DJ, Pilewski JM, Orenstein DM, Miller E
Journal of pediatric and adolescent gynecology
Provider Attitudes and Practices toward Sexual and Reproductive Health Care for Young Women with Cystic Fibrosis. J Pediatr Adolesc Gynecol. 2017 Oct; 30(5):546-552.
Provider Attitudes and Practices toward Sexual and Reproductive Health Care for Young Women with Cystic Fibrosis.
Battistini L, Borsellino G, Sawicki G, Poccia F, Salvetti M, Ristori G, Brosnan CF
Journal of immunology (Baltimore, Md. : 1950)
Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol. 1997 Oct 15; 159(8):3723-30.
Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors.
Counterpoint: Too little care or too little collaboration: Approaches to treatment refusal in CF. J Cyst Fibros. 2017 03; 16(2):304-305.
Counterpoint: Too little care or too little collaboration: Approaches to treatment refusal in CF.
Friedman D, Linnemann RW, Altstein LL, Islam S, Bach KT, Lamb C, Volpe J, Doolittle C, St John A, O'Malley PJ, Sawicki GS, Georgiopoulos AM, Yonker LM, Moskowitz SM
The CF-CARES primary palliative care model: A CF-specific structured assessment of symptoms, distress, and coping. J Cyst Fibros. 2018 01; 17(1):71-77.
The CF-CARES primary palliative care model: A CF-specific structured assessment of symptoms, distress, and coping.
Adherence and Recursive Perception Among Young Adults with Cystic Fibrosis. Anthropol Med. 2017 Apr; 24(1):65-80.
Adherence and Recursive Perception Among Young Adults with Cystic Fibrosis.
McGuffie K, Sellers DE, Sawicki GS, Robinson WM
Self-reported involvement of family members in the care of adults with CF. J Cyst Fibros. 2008 Mar; 7(2):95-101.
Self-reported involvement of family members in the care of adults with CF.
Sobin L, Kawai K, Irace AL, Gergin O, Cunningham M, Sawicki GS, Adil EA
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients. Otolaryngol Head Neck Surg. 2017 08; 157(2):302-308.
Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients.
Early Lung Function Decline in Cystic Fibrosis. Can Registry Data Explain Divergent Phenotypes? Am J Respir Crit Care Med. 2017 08 15; 196(4):407-409.
Early Lung Function Decline in Cystic Fibrosis. Can Registry Data Explain Divergent Phenotypes?
Wisk LE, Finkelstein JA, Toomey SL, Sawicki GS, Schuster MA, Galbraith AA
Impact of an Individual Mandate and Other Health Reforms on Dependent Coverage for Adolescents and Young Adults. Health Serv Res. 2018 06; 53(3):1581-1599.
Impact of an Individual Mandate and Other Health Reforms on Dependent Coverage for Adolescents and Young Adults.
High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros. 2009 Mar; 8(2):91-6.
High treatment burden in adults with cystic fibrosis: challenges to disease self-management.
Sawicki GS, McKone EF, Millar SJ, Pasta DJ, Konstan MW, Lubarsky B, Wagener JS
Patients with Cystic Fibrosis and a G551D or Homozygous F508del Mutation: Similar Lung Function Decline. Am J Respir Crit Care Med. 2017 06 15; 195(12):1673-1676.
Patients with Cystic Fibrosis and a G551D or Homozygous F508del Mutation: Similar Lung Function Decline.
Greenberg J, Prushinskaya O, Harris JD, Guidetti-Myers G, Steiding J, Sawicki GS, Gaffin JM
Utilization of a patient-centered asthma passport tool in a subspecialty clinic. J Asthma. 2018 02; 55(2):180-187.
Utilization of a patient-centered asthma passport tool in a subspecialty clinic.
Sawicki GS, Garvey KC, Toomey SL, Williams KA, Hargraves JL, James T, Raphael JL, Giardino AP, Schuster MA, Finkelstein JA
Preparation for Transition to Adult Care Among Medicaid-Insured Adolescents. Pediatrics. 2017 Jul; 140(1).
Preparation for Transition to Adult Care Among Medicaid-Insured Adolescents.
Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA
Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J. 2008 Jun; 31(6):1285-91.
Necrotising pneumonia is an increasingly detected complication of pneumonia in children.
Sawicki GS, Dill EJ, Asher D, Sellers DE, Robinson WM
Advance care planning in adults with cystic fibrosis. J Palliat Med. 2008 Oct; 11(8):1135-41.
Advance care planning in adults with cystic fibrosis.
Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample. Qual Life Res. 2012 Sep; 21(7):1279-90.
Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample.
Lee EY, Vargas SO, Sawicki GS, Boyer D, Grant FD, Voss SD
Mucoepidermoid carcinoma of bronchus in a pediatric patient: (18)F-FDG PET findings. Pediatr Radiol. 2007 Dec; 37(12):1278-82.
Mucoepidermoid carcinoma of bronchus in a pediatric patient: (18)F-FDG PET findings.
Gaffin JM, Sheehan WJ, Morrill J, Cinar M, Borras Coughlin IM, Sawicki GS, Twarog FJ, Young MC, Schneider LC, Phipatanakul W
Tree nut allergy, egg allergy, and asthma in children. Clin Pediatr (Phila). 2011 Feb; 50(2):133-9.
Tree nut allergy, egg allergy, and asthma in children.
Barsky EE, Williams KA, Priebe GP, Sawicki GS
Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis. Pediatr Pulmonol. 2017 10; 52(10):1276-1282.
Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.
Kazmerski TM, Sawicki GS, Miller E, Jones KA, Abebe KZ, Tuchman LK, Ladores S, Rubenstein RC, Sagel SD, Weiner DJ, Pilewski JM, Orenstein DM, Borrero S
Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis. J Cyst Fibros. 2018 01; 17(1):57-63.
Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis.
Dellon E, Goldfarb SB, Hayes D, Sawicki GS, Wolfe J, Boyer D
Pediatric lung transplantation and end of life care in cystic fibrosis: Barriers and successful strategies. Pediatr Pulmonol. 2017 Nov; 52(S48):S61-S68.
Pediatric lung transplantation and end of life care in cystic fibrosis: Barriers and successful strategies.
Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis. J Cyst Fibros. 2018 01; 17(1):64-70.
Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis.
Mental Health Screening of Medically-Admitted Patients With Cystic Fibrosis. Psychosomatics. 2018 Mar - Apr; 59(2):158-168.
Mental Health Screening of Medically-Admitted Patients With Cystic Fibrosis.
The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun; 47(6):582-7.
The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis.
Wagener JS, Millar SJ, Mayer-Hamblett N, Sawicki GS, McKone EF, Goss CH, Konstan MW, Morgan WJ, Pasta DJ, Moss RB
Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation. J Cyst Fibros. 2018 07; 17(4):503-510.
Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation.
Barsky EE, Pereira LM, Sullivan KJ, Wong A, McAdam AJ, Sawicki GS, Priebe GP, Goobie SM
Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis. J Cyst Fibros. 2018 05; 17(3):e25-e31.
Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis.
Advances in neonatal care : official journal of the National Association of Neonatal Nurses
Assessment of current strategies for weaning premature infants from supplemental oxygen in the outpatient setting. Adv Neonatal Care. 2011 Oct; 11(5):349-56.
Assessment of current strategies for weaning premature infants from supplemental oxygen in the outpatient setting.
Sawicki GS, Sellers DE, McGuffie K, Robinson W
Adults with cystic fibrosis report important and unmet needs for disease information. J Cyst Fibros. 2007 Nov 30; 6(6):411-6.
Adults with cystic fibrosis report important and unmet needs for disease information.
Sawicki GS, Ostrenga J, Petren K, Fink AK, D'Agostino E, Strassle C, Schechter MS, Rosenfeld M
Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States. Ann Am Thorac Soc. 2018 02; 15(2):234-240.
Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.
Konstan MW, VanDevanter DR, Sawicki GS, Pasta DJ, Foreman AJ, Neiman EA, Morgan WJ
Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis. Ann Am Thorac Soc. 2018 04; 15(4):485-493.
Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis.
Sawicki GS, Signorovitch JE, Zhang J, Latremouille-Viau D, von Wartburg M, Wu EQ, Shi L
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution. Pediatr Pulmonol. 2012 Jan; 47(1):44-52.
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution.
Managing treatment complexity in cystic fibrosis: challenges and opportunities. Pediatr Pulmonol. 2012 Jun; 47(6):523-33.
Managing treatment complexity in cystic fibrosis: challenges and opportunities.
Self-reported physical and psychological symptom burden in adults with cystic fibrosis. J Pain Symptom Manage. 2008 Apr; 35(4):372-80.
Self-reported physical and psychological symptom burden in adults with cystic fibrosis.
Sawicki GS, Rasouliyan L, Pasta DJ, Regelmann WE, Wagener JS, Waltz DA, Ren CL
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol. 2008 Nov; 43(11):1117-1123.
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis.
Sawicki GS, Ayyagari R, Zhang J, Signorovitch JE, Fan L, Swallow E, Latremouille-Viau D, Wu EQ, Shi L
A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care. Pediatr Pulmonol. 2013 Oct; 48(10):954-61.
A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care.